BioCentury
ARTICLE | Clinical News

R343: Development discontinued

September 2, 2013 7:00 AM UTC

Rigel discontinued development of R343 after the double-blind, international Phase II SITAR trial in about 300 patients with mild to moderate allergic asthma showed that twice-daily inhaled R343 misse...